MBOT
Microbot Medical Inc. (NASDAQ)
Healthcare — Medical Instruments & Supplies
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Price History
Fundamentals
| Market Cap | $128.28M |
| P/E Ratio (TTM) | - |
| Forward P/E | -5.97 |
| EPS (TTM) | $-0.26 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -27.58% |
| Debt/Equity | 1.21 |
| Recommendation | Strong Buy 1.0 |
| Analyst Target | $7.00 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 63.5 |
| Beta | 1.03 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $4.67 |
| 52-Week Low | $1.60 |
| 50-Day Avg | $1.95 |
| 200-Day Avg | $2.28 |
| Avg Volume | $1.26M |
| Volume | 413.8K |
Performance Analysis
BULLISHMBOT shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:19 UTC
Back to Screener Export Report